<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saito AN</submitter><funding>Takeda Science Foundation</funding><funding>Japan Society for the Promotion of Science</funding><pagination>1720-1728</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9680855</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(11)</volume><pubmed_abstract>The circadian clock, an internal time-keeping system with a period of about 24 h, coordinates many physiological processes with the day-night cycle. We previously demonstrated that BML-259 [N-(5-isopropyl-2-thiazolyl) phenylacetamide], a small molecule with mammal CYCLIN DEPENDENT KINASE 5 (CDK5)/CDK2 inhibition activity, lengthens Arabidopsis thaliana (Arabidopsis) circadian clock periods. BML-259 inhibits Arabidopsis CDKC kinase, which phosphorylates RNA polymerase II in the general transcriptional machinery. To accelerate our understanding of the inhibitory mechanism of BML-259 on CDKC, we performed structure-function studies of BML-259 using circadian period-lengthening activity as an estimation of CDKC inhibitor activity in vivo. The presence of a thiazole ring is essential for period</pubmed_abstract><journal>Plant &amp; cell physiology</journal><pubmed_title>Structure-Function Study of a Novel Inhibitor of Cyclin-Dependent Kinase C in Arabidopsis.</pubmed_title><pmcid>PMC9680855</pmcid><funding_grant_id>18H04428</funding_grant_id><funding_grant_id>20H05411</funding_grant_id><funding_grant_id>20K21272</funding_grant_id><funding_grant_id>21H05656</funding_grant_id><pubmed_authors>Matsuo H</pubmed_authors><pubmed_authors>Fujimoto KJ</pubmed_authors><pubmed_authors>Maeda AE</pubmed_authors><pubmed_authors>Nakamichi N</pubmed_authors><pubmed_authors>Nishina M</pubmed_authors><pubmed_authors>Yanai T</pubmed_authors><pubmed_authors>Ota E</pubmed_authors><pubmed_authors>Notaguchi M</pubmed_authors><pubmed_authors>Saito AN</pubmed_authors><pubmed_authors>Takahara TT</pubmed_authors><pubmed_authors>Kinoshita T</pubmed_authors><pubmed_authors>Yamaguchi J</pubmed_authors><pubmed_authors>Ono A</pubmed_authors><pubmed_authors>Shiratake K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure-Function Study of a Novel Inhibitor of Cyclin-Dependent Kinase C in Arabidopsis.</name><description>The circadian clock, an internal time-keeping system with a period of about 24 h, coordinates many physiological processes with the day-night cycle. We previously demonstrated that BML-259 [N-(5-isopropyl-2-thiazolyl) phenylacetamide], a small molecule with mammal CYCLIN DEPENDENT KINASE 5 (CDK5)/CDK2 inhibition activity, lengthens Arabidopsis thaliana (Arabidopsis) circadian clock periods. BML-259 inhibits Arabidopsis CDKC kinase, which phosphorylates RNA polymerase II in the general transcriptional machinery. To accelerate our understanding of the inhibitory mechanism of BML-259 on CDKC, we performed structure-function studies of BML-259 using circadian period-lengthening activity as an estimation of CDKC inhibitor activity in vivo. The presence of a thiazole ring is essential for period</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-04-08T11:06:32.928Z</modification><creation>2025-04-19T06:03:29.961Z</creation></dates><accession>S-EPMC9680855</accession><cross_references><pubmed>36043692</pubmed><doi>10.1093/pcp/pcac127</doi></cross_references></HashMap>